Literature DB >> 22460357

The role of FK506-binding proteins 12 and 12.6 in regulating cardiac function.

Bai-Yan Li1, Hanying Chen, Mitsunori Maruyama, Wenjun Zhang, Jin Zhang, Zhen-Wei Pan, Michael Rubart, Peng-Sheng Chen, Weinian Shou.   

Abstract

Specifically, FK506-binding proteins 12 (FKBP12) and 12.6 (FKBP12.6) are cis-trans peptidyl prolyl isomerases that are expressed in the heart. Both FKBP12 and FKBP12.6 were previously known to interact with ryanodine receptors in striated muscles. Although FKBP12 is abundantly present in the heart, its function in the heart is largely uncertain. Recently, by generating FKBP12 transgenic overexpression and cardiac-restricted knockout mice, we showed that FKBP12 is critically important in regulating trans-sarcolemmal ionic currents, predominately the voltage-gated Na+ current, I(Na), but it appears to be less important for regulating cardiac ryanodine receptor function. Similar genetic approaches also confirm the role of FKBP12.6 in regulating cardiac ryanodine receptors. The current study demonstrated that FKBP12 and FKBP12.6 have very different physiologic functions in the heart.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460357      PMCID: PMC3582179          DOI: 10.1007/s00246-012-0298-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  33 in total

Review 1.  Ryanodine receptors, FKBP12, and heart failure.

Authors:  Andrew R Marks
Journal:  Front Biosci       Date:  2002-04-01

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

3.  Phenotyping hypertrophy: eschew obfuscation.

Authors:  Gerald W Dorn; Jeffrey Robbins; Peter H Sugden
Journal:  Circ Res       Date:  2003-06-13       Impact factor: 17.367

4.  Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

Authors:  Hong-Bo Xin; Takaaki Senbonmatsu; Dong-Sheng Cheng; Yong-Xiao Wang; Julio A Copello; Guang-Ju Ji; Mei Lin Collier; Ke-Yu Deng; Loice H Jeyakumar; Mark A Magnuson; Tadashi Inagami; Michael I Kotlikoff; Sidney Fleischer
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

5.  FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes.

Authors:  Guillermo Avila; Eun Hui Lee; Claudio F Perez; P D Allen; Robert T Dirksen
Journal:  J Biol Chem       Date:  2003-04-17       Impact factor: 5.157

6.  Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release.

Authors:  Ying Liu; Hanying Chen; Guangju Ji; Baiyan Li; Peter J Mohler; Zhiming Zhu; Weidong Yong; Zhuang Chen; Xuehong Xu; Hongbo Xin; Weinian Shou
Journal:  Assay Drug Dev Technol       Date:  2011-11-16       Impact factor: 1.738

7.  Three-dimensional localization of divergent region 3 of the ryanodine receptor to the clamp-shaped structures adjacent to the FKBP binding sites.

Authors:  Jing Zhang; Zheng Liu; Haruko Masumiya; Ruiwu Wang; Dawei Jiang; Fei Li; Terence Wagenknecht; S R Wayne Chen
Journal:  J Biol Chem       Date:  2003-02-07       Impact factor: 5.157

8.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Authors:  Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

9.  Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor).

Authors:  Haruko Masumiya; Ruiwu Wang; Jing Zhang; Bailong Xiao; S R Wayne Chen
Journal:  J Biol Chem       Date:  2002-11-22       Impact factor: 5.157

10.  FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Fannie Huang; John A Vest; Steven R Reiken; Peter J Mohler; Jie Sun; Silvia Guatimosim; Long Sheng Song; Nora Rosemblit; Jeanine M D'Armiento; Carlo Napolitano; Mirella Memmi; Silvia G Priori; W J Lederer; Andrew R Marks
Journal:  Cell       Date:  2003-06-27       Impact factor: 41.582

View more
  1 in total

Review 1.  Rapalogs and mTOR inhibitors as anti-aging therapeutics.

Authors:  Dudley W Lamming; Lan Ye; David M Sabatini; Joseph A Baur
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.